In obesity, some types of tissue/cell damage may involve activation of endogenous CNTF signalling which, by virtue of its catabolic action, has the potential to counteract some adverse effects of obesity and of the associated metabolic syndrome. The gene discussed is CNTF; the disease is obesity due to melanocortin 4 receptor deficiency.